PTLA—3Q18 sales of Bevyxxa were zero: https://globenewswire.com/news-release/2018/11/07/1647395/0/en/Portola-Pharmaceuticals-Reports-Third-Quarter-2018-Financial-Results-and-Provides-Corporate-Update.html Andexxa sales were $7.7M (whoopee).